US 9296746
Heterocyclic compound
granted A61PA61P25/00A61P25/14
Quick answer
US patent 9296746 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/28